In their meta-analysis of 1649 patients, Jin et al. analyzed eight studies and showed an association between elevated CRP levels and worse survival in patients with both primary resectable NSCLC and primary unresectable NSCLC [33]. This evidence concerns the gene CRP and non-small cell lung carcinoma.